135 related articles for article (PubMed ID: 26607)
1. Dopaminephilic properties of ergot alkaloids.
Goldstein M; Lew JY; Nakamura S; Battista AF; Lieberman A; Fuxe K
Fed Proc; 1978 Jun; 37(8):2202-6. PubMed ID: 26607
[No Abstract] [Full Text] [Related]
2. [Dopamine agonists in the therapy of parkinson syndrome].
Kapfhammer HP; Rüther E
Nervenarzt; 1985 Feb; 56(2):69-81. PubMed ID: 3982566
[No Abstract] [Full Text] [Related]
3. Dopamine agonist potencies of ergolines.
Lew JY; Nakamura S; Battista AF; Goldstein M
Commun Psychopharmacol; 1979; 3(3):179-83. PubMed ID: 115634
[No Abstract] [Full Text] [Related]
4. Comparison between lergotrile and bromocriptine in parkinsonism.
Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
[TBL] [Abstract][Full Text] [Related]
5. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
[No Abstract] [Full Text] [Related]
6. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
[TBL] [Abstract][Full Text] [Related]
7. Effect of dopaminephilic agents and cAMP on tyrosine hydroxylase activity.
Goldstein M; Bronaugh RL; Lew JU; Ohashi T; Drummond GS; Fuxe K
Adv Biochem Psychopharmacol; 1977; 16():447-53. PubMed ID: 18892
[No Abstract] [Full Text] [Related]
8. Treatment of Parkinson's disease with lergotrile mesylate.
Lieberman A; Estey E; Kupersmith M; Gopinathan G; Goldstein M
JAMA; 1977 Nov; 238(22):2380-2. PubMed ID: 335094
[TBL] [Abstract][Full Text] [Related]
9. [Biochemical bases of Parkinson disease].
Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
[No Abstract] [Full Text] [Related]
10. Binding interactions of ergot alkaloids with monoaminergic receptors in the brain.
Goldstein M; Lew JY; Hata F; Lieberman A
Gerontology; 1978; 24 Suppl 1():76-85. PubMed ID: 22480
[TBL] [Abstract][Full Text] [Related]
11. Dopamine agonists and Parkinson's disease.
Burton K; Calne DB
Clin Neurol Neurosurg; 1984; 86(3):172-7. PubMed ID: 6091965
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine, lergotrile: the antiparkinsonian efficacy and the interaction with monoaminergic receptors.
Goldstein M; Lieberman A; Battista AF; Lew JY; Hata F
Pharmacology; 1978; 16 Suppl 1():143-9. PubMed ID: 25445
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
Frantz AG; Kleinberg DL
Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
[TBL] [Abstract][Full Text] [Related]
14. Role of ergot derivatives in the treatment of parkinsonism.
Calne DB
Fed Proc; 1978 Jun; 37(8):2207-9. PubMed ID: 658459
[No Abstract] [Full Text] [Related]
15. An ergot derivative in the treatment of Parkinson's disease.
Calne DB; Shoulson I; Kartzinel R
Postgrad Med J; 1976; 52suppl 1():81-5. PubMed ID: 183198
[No Abstract] [Full Text] [Related]
16. Experimental and clinical studies on bromocriptine in the Parkinsonian syndrome.
Goldstein M; Lieberman A; Battista AF; Lew JY; Matsumoto Y
Acta Endocrinol Suppl (Copenh); 1978; 216():57-66. PubMed ID: 206089
[No Abstract] [Full Text] [Related]
17. Long-term use of dopamine agonists in Parkinson's disease.
Jankovic J
Clin Neuropharmacol; 1985; 8(2):131-40. PubMed ID: 3891082
[No Abstract] [Full Text] [Related]
18. Parkinson's disease: from brain homogenate to treatment.
Hornykiewicz O
Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
[No Abstract] [Full Text] [Related]
19. DA agonists -- ergot derivatives: cabergoline: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S68-71. PubMed ID: 12211142
[No Abstract] [Full Text] [Related]
20. Bromocriptine in Parkinson disease.
Lieberman AN; Goldstein M
Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
